Literature DB >> 17948965

Upregulation of MICA on high-grade invasive operable breast carcinoma.

Zahra Madjd1, Ian Spendlove, Robert Moss, Shaun Bevin, Sarah E Pinder, Nicholas F S Watson, Ian Ellis, Lindy G Durrant.   

Abstract

The MHC class I chain-related gene A (MICA) is frequently expressed on the surface of intestinal epithelium and by many epithelial tumours. MICA is a stress-induced antigen which was identified as an activator of natural killer cells via interaction with the NKG2D receptor. We have raised a rabbit polyclonal antibody against a synthetic peptide that recognises denatured MICA on both Western blots and in formalin-fixed paraffin-embedded sections. In the present study this antibody was used to undertake a definitive study of 530 breast cancer cases with mean follow up of 7 years to determine the prognostic significance of MICA expression. To detect any association between MICA expression and NK infiltration, whole sections of 50 tumours were also analysed for CD56 staining. Univariate analysis showed significant relationships between MICA expression and histological grade (P = 0.006), lymph node stage (P = 0.013), Nottingham Prognostic Index (NPI, P = 0.002), the presence of vascular invasion (P = 0.045) and tumour type (P = 0.023). Upregulation of MICA was more often found in histological grade 3, poor prognosis (NPI >5.4) tumours. Association of high MICA expression with NK cell infiltration was not demonstrated, as very few NK cells were present in whole breast sections. Our results suggest that induced expression of MICA may be an indicator of poor prognosis in breast carcinoma and is indicative of a tumour environment that has undergone stresses such as apoptosis, necrosis, or hypoxia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948965      PMCID: PMC2935745     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN: 1424-9634


  44 in total

1.  Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer.

Authors:  F S Kenny; P C Willsher; J M Gee; R Nicholson; S E Pinder; I O Ellis; J F Robertson
Journal:  Breast Cancer Res Treat       Date:  2001-01       Impact factor: 4.872

2.  NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment.

Authors:  A I Roberts; L Lee; E Schwarz; V Groh; T Spies; E C Ebert; B Jabri
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 3.  MICA and MICB genes: can the enigma of their polymorphism be resolved?

Authors:  H A Stephens
Journal:  Trends Immunol       Date:  2001-07       Impact factor: 16.687

4.  Typing for all known MICA alleles by group-specific PCR and SSOP.

Authors:  Y Zhang; A M Lazaro; B Lavingia; P Stastny
Journal:  Hum Immunol       Date:  2001-06       Impact factor: 2.850

5.  Clinical and histological predictors of contralateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  Eur J Surg Oncol       Date:  1999-12       Impact factor: 4.424

6.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

7.  Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up.

Authors:  I O Ellis; M Galea; N Broughton; A Locker; R W Blamey; C W Elston
Journal:  Histopathology       Date:  1992-06       Impact factor: 5.087

8.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

9.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

10.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

View more
  29 in total

Review 1.  The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.

Authors:  André Steven; Barbara Seliger
Journal:  Breast Care (Basel)       Date:  2018-02-02       Impact factor: 2.860

2.  Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.

Authors:  Gang Liu; Shengjun Lu; Xuanjun Wang; Stephanie T Page; Celestia S Higano; Stephen R Plymate; Norman M Greenberg; Shaoli Sun; Zihai Li; Jennifer D Wu
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

Review 3.  NKG2D ligands as therapeutic targets.

Authors:  Paul Spear; Ming-Ru Wu; Marie-Louise Sentman; Charles L Sentman
Journal:  Cancer Immun       Date:  2013-05-01

4.  The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosis.

Authors:  Gustav J Ullenhag; Ahmad Al-Attar; Abhik Mukherjee; Andrew R Green; Ian O Ellis; Lindy G Durrant
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-18       Impact factor: 4.553

5.  MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.

Authors:  Yu Chen; Jing Lin; Zeng-Qing Guo; Wan-Song Lin; Zhi-Feng Zhou; Chuang-Zhong Huang; Qiang Chen; Yun-Bin Ye
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

6.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

7.  Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.

Authors:  Kyle K Payne; Christine K Zoon; Wen Wan; Khin Marlar; Rebecca C Keim; Mehrab Nasiri Kenari; A Latif Kazim; Harry D Bear; Masoud H Manjili
Journal:  Breast Cancer Res Treat       Date:  2013-10-25       Impact factor: 4.872

8.  CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.

Authors:  Zahra Madjd; Ali Zare Mehrjerdi; Ali Mohammad Sharifi; Saadat Molanaei; Shahriar Zohourian Shahzadi; Mohsen Asadi-Lari
Journal:  Cancer Immun       Date:  2009-04-23

9.  MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility.

Authors:  Arnoldo Aquino-Galvez; Martha Pérez-Rodríguez; Angel Camarena; Ramces Falfan-Valencia; Víctor Ruiz; Martha Montaño; Lourdes Barrera; Isabel Sada-Ovalle; Remedios Ramírez; Julio Granados; Annie Pardo; Moisés Selman
Journal:  Hum Genet       Date:  2009-04-12       Impact factor: 4.132

10.  Effects of MICA expression on the prognosis of advanced non-small cell lung cancer and the efficacy of CIK therapy.

Authors:  Yu Chen; Gen Lin; Zeng-qing Guo; Zhi-feng Zhou; Zhi-yong He; Yun-bin Ye
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.